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ELISABETH CARNIEL
This chapter contains a brief overview of plague today (current foci, epidemiology,
clinical symptoms, causative agent, treatment, and prophylaxis), as seen from the view-
point of the medical and scientific community. It is not an ‘‘argument’’ but a description of
our current observations and understanding of the disease.
Three plague pandemics are traditionally described during the Christian era. The first
pandemic, designated ‘‘the plague of Justinian’’, broke out in Egypt in 541; the second,
knownasthe‘‘BlackDeath’’,eruptedinMessina,Sicily,in1347;andthethirdbeganinthe
war-torn Yunnan province of China and reached Hong Kong in 1894. The network of
steamships and railways favoured a rapid spread of the disease over all continents and the
colonization of previously unscathed areas. Major advances in the knowledge of plague
were made during the early years of the last pandemic. In 1894, Alexandre Yersin identi-
fied the aetiologic agent (Yersinia pestis) and showed that rats are a reservoir of the
disease.
1 Four years later, Paul-Louis Simond demonstrated that plague is transmitted
by fleas.
2 Thanks to the advent of effective public health measures, mass vaccination in
1934, and antibiotic therapy in 1938, the number of victims reported during the third
pandemic was in no way comparable to those of the previous two.
Plague Today
Despite a considerable reduction in mortality and morbidity, plague has not been
eradicated. Endemic foci persist in Africa, North and South America, and Asia. During
the nineteen years from 1985 to2003, over 43,000 humancases were reported tothe World
Health Organization by twenty-five countries.
3 The worldwide numbers are most likely
underestimated because of unrecognized cases and the failure of some countries to report
occurrences of plague.
Since the beginning of the 1990s, a sharp rise in the number of human plague cases has
beenobserved(Figure1).Thisriseispartlyattributabletothereappearanceofepidemicsin
countriesorregionswherehumanplaguehaddisappearedforseveraldecades.Thiswasthe
casein1991intheseaportofMahajanga(Madagascar)afteranabsenceofoversixtyyears,
in 1994 in Malawi, Zimbabwe, Mozambique and India (where no case had been reported
during nearly thirty years), in 1996 in Zambia and some provinces of China, in 1997 in
Jordan (with no plague cases during eighty years), and more recently in Algeria (2003)
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1Alexandre Yersin, ‘La peste bubonique a ` Hong-Kong’, Ann. Inst. Pasteur, 1894, 8: 662–7.
2Paul-Louis Simond, ‘La propagation de la peste’, Ann. Inst. Pasteur, 1898, 12: 625–87.
3WHO,‘Humanplaguein1998and1999’,Wkly.Epidemiol.Rec.,2000,42:337–44;WHO,‘Humanplaguein
2002 and 2003’, Wkly. Epidemiol. Rec. 2004, 79: 301–8.
115after over fifty years with no outbreaks. For this reason, the plague is now categorized as a
reemerging disease.
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Plague: Epidemiology
Reservoir
Plague primarily affects rodents but several other animal species including cats, rabbits,
camelsandhumanscanalsobeinfected.Over200rodentspeciesin73generaworldwideare
susceptible in various degrees to the disease. Sporadically or periodically, explosive out-
breaks occur among populations of susceptible rodents. The animal species constituting the
naturalplaguereservoirvarygreatlydependingonthegeographicallocationofthefoci.Forin-
stance,ratsrepresentthecommonsourceofhumanplaguecasesinMadagascarandVietnam,
while large gerbils in central Kazakhstan and meriones in Iran are the main reservoirs.
Vector
Plague is generally transmitted via the bites of fleas. Maintenance of plague in nature is
totally dependent upon the cyclical transmission between fleas and mammals. More than
eighty different species of flea are implicated in maintaining the plague cycle. These
species and their transmission efficacy vary from country to country, depending on the
characteristics of the ecological niches (reservoir species, climate, etc.).
4StephanieJ Schrag and Pamela Wiener, ‘Emerging infectious diseases: what are the relative roles of ecology
and evolution?’, Trends Evol. Ecol., 1995, 10 (8): 319–24.
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Figure 1: Annual numbers of human plague cases reported to WHO between 1985 and 2003.
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Elisabeth CarnielWhile feeding on an infected host at a bacteremic/septicaemic stage, the ectoparasite
ingests the bacilli present in the bloodstream. The bacteria multiply in the mid gut of the
insect, eventually forming a solid mass that blocks its proventriculus.
5 The flea that most
commonly becomes blocked is the rat flea, Xenopsylla cheopis. During repeated attempts
to feed on a new host, the hungry blocked flea is unable to pump blood into its stomachand
subsequently regurgitates the bacteria into the bite wound.
The accepted paradigm over the last several decades was that only blocked fleas could
efficiently transmit the disease. However, recent work has demonstrated that Oropsylla
montana,thefleacommonlyfoundonhighlyplague-susceptiblegroundandrocksquirrels,
and the primary vector to humans in North America, can efficiently and rapidly transmit
the disease without any blockage of its proventriculus.
6 These results also suggest that the
human flea, Pulex irritans, very prevalent on individuals during the Middle Ages, but
which was disregarded as a potential human-to-human vector because of its poor blocking
capacity, may actually have played a key role in the rapid spread of the Black Death.
Foci
Plague foci exist in a number of countries with landscapes, climates and altitudes that
vary considerably. The central Kazakhstan focus, for instance, is a large zone of dry desert
atsea level with very hotsummersandextremelycold winters.This iscompletely different
to the Madagascar focus, which is at high altitude (>1000m) and has a temperate climate
with sometimes high humidity and often a rich vegetation.
7 Numerous intermediate land-
scapes between these two extremes exist in the world. These various ecological niches
determine the different types of reservoirs and flea vectors, and consequently influence the
incidence of human plague.
In almost all plague foci, animal and human infections are not found all the year round
but predominate during the so-called ‘‘plague season’’. This season is usually constant in a
given area, but differs from focus to focus, depending on the environmental characteristics
(climate, altitude, etc.).
8 Variations in seasonality can even be observed within the same
country. In Madagascar for instance, the plague season is between October and March on
the high plateaux, and between July and November on the coast.
9 Similarly, a difference in
seasonality is observed for the coastal and high plateau foci of Vietnam.
Human Infections
Rodent-to-human plague transmission most commonly occurs via infected fleas asso-
ciated with peridomestic animals (rats, cats) or wild rodents. Although rare, infection may
5A W Bacot and C J Martin, ‘Observations on the mechanisms of the transmission of plague by fleas’,
J. Hygiene, 1914, 13 (suppl. 3): 423–39.
6RJEisen,SWBearden,APWilder,JAMontenieri,MFAntolin,andKLGage,‘Early-phasetransmissionof
Yersinia pestis by unblocked fleas as a mechanism explaining rapidly spreading plague epizootics’, Proc. Natl.
Acad. Sci. USA, 2006, 103 (42): 15380–85.
7Suzanne Chanteau (ed.), Atlas de la peste a ` Madagascar, Paris, IRD, Institut Pasteur, AUF, 2006.
8Robert Pollitzer, Plague, Geneva, World Health Organization, 1954, pp. 486–90.
9Chanteau (ed.), op. cit., note 7 above, p. 53.
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Plague Todayalso result from direct exposure (through conjunctiva or cutaneous excoriations) to con-
taminated fluids or by inhalation of infected aerosols, for instance during the manipulation
of animal furs. Human-to-human transmission may occur by inhalation of infected respira-
tory droplets spread by a patient suffering from pneumonic plague.
Differences in the age and sex incidence of bubonic plague cases are observed but are
due merely to differences in the degree of exposure of the various groups to the infection
rather than to intrinsic causes. In India, females were more frequently infected, whereas in
Manchuria males were at higher risk of infection.
10 Within the same country, the sex ratio
may differ between urban and rural areas. Similarly, although plague may more commonly
affect one age group, this group is not the same everywhere. Usually, adolescents and
adults are considered the most at risk, but the infection predominates in children in several
foci such as those of Madagascar and Brazil.
Plague: Clinical Symptoms
General Symptoms
The two major clinical forms of plague are bubonic and pneumonic.
11 In both forms, the
incubation period usually varies from a few hours to five or six days, although longer times
(up to ten or fifteen days) have sometimes been reported. In the majority of plague attacks,
the onset of the disease is sudden and severe. It is characterized by a rapid rise in
temperature, which reaches 39.5Ct o4 0 C in a few hours, accompanied by an incessant
quickening of the pulse and a fall in blood pressure, indicative of progressive heart failure.
Symptoms of alteration of the nervous system are very common and show individual
variations characterized by delirium and restless agitation in some patients, and apathy and
stuporinothers.Vomitingisconsideredausualsymptombysomephysicians,butnotsoby
others. Unless adequate specific treatment is administered, the condition of the patient
deteriorates rapidly and death most commonly occurs within three to five days.
Bubonic Plague
Bubonic plague, the most common form of the disease, is acquired after the bite of an
infected flea. At the site of the bite, the bacteria multiply and sometimes cause a small
vesicle that develops into a painful, dark and necrotic carbuncle. Although not always
present, this skin lesion is a valuable indication for the clinical diagnosis of plague. The
bacilli then disseminate via the lymphatic vessels and reach the proximal draining lymph
node where they multiply, causing an extremely tender tumefaction known as a bubo.
Although the bubo usually forms at one site only, bilateral and multiple locations are also
observed. In the best cases, the bubo spontaneously suppurates and the patient recovers
fromthe infection.Most frequently,the bacterium disseminatesviathe blood vesselstothe
spleen, liver and sometimes the lungs, causing septicaemia that is soon fatal. In patients
suffering from a severe type of the infection, localized or diffused skin haemorrhages
10Pollitzer, op. cit., note 8 above, pp. 503–4.
11Ibid., pp. 409–82.
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Elisabeth Carniel(petechiae or ecchymoses) may be a frequent complication. In the absence of appropriate
treatment, the mortality rate of bubonic plague victims ranges from 40 to 70 per cent.
Pneumonic Plague
Although less frequent, pneumonic plague is an even more severe form of the disease.
Individuals contract it through inhalation of infected droplets spread by a patient who had
developed a lung infection,either as a secondary complication of a bubonic form, or after a
primary pulmonary contamination. In addition to the general symptoms described above,
the patients exhibit signs of lung involvement such as cough, muco-purulent and bloody
sputum, dyspnoea and pain in the chest. Without treatment, the outcome of pneumonic
plague is invariably fatal, usually in less than three days. However, in a number of
instances, survival for nine to ten days has been recorded.
Other Clinical Forms of Plague
Besides the classic symptoms characteristic of bubonic and pneumonic plague, Yersinia
pestis infection may show various clinical presentations in which septicaemic, meningeal,
haemorrhagic, gastro-intestinal, or pharyngeal symptoms predominate. Benign, fulminant
and even chronic forms of plague may also exist. Despite this large array of potential
clinical symptoms, the plague is, nonetheless, a disease which is easily recognized, not
only by physicians, but also by health agents and the population living in endemic areas.
Plague: The Aetiological Agent
The agent of plague, Yersinia pestis, is a small Gram-negative bacillus belonging to
the genus Yersinia. This genus is part of the family Enterobacteriaceae and comprises
twelve species, of which only three are human pathogens: Yersinia pestis, Yersinia
pseudotuberculosis and Yersinia enterocolitica. Yersinia pseudotuberculosis and Yersinia
enterocolitica differ epidemiologically and clinically from Yersinia pestis as they are
enteropathogenic bacteria transmitted by the oral route. Despite strikingly different
clinical manifestations and epidemiological cycles, DNA-DNA hybridization experiments
indicated that Yersinia pestis is genetically almost identical to Yersinia pseudotuberculosis
(>90percentchromosomalrelatedness).
12Recently,multilocussequencetypingconfirmed
the high genetic relatedness between Yersinia pestis and Yersinia pseudotuberculosis and
showed that Yersinia pestis is a highly clonal species.
13
In species where horizontal genetic exchange is rare, sequence polymorphism reflects
the accumulation of mutations at a uniform clock rate and correlates with the time elapsed
since the existence of a last common ancestor. Using the combination of two different
12Herve ´ Bercovier, et al., ‘Intra- and interspecies relatedness of Yersinia pestis by DNA hybridization and its
relationship to Yersinia pseudotuberculosis’, Current Microbiology,1980, 4: 225–9.
13M Achtman, K Zurth, G Morelli, G Torrea, A Guiyoule, and E Carniel, ‘Yersinia pestis, the cause of
plague, is a recently emerged clone of Yersinia pseudotuberculosis’, Proc. Natl. Acad. Sci. USA, 1999, 96 (24):
14043–48.
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Plague Todayclock rates, it was possible to establish that the Yersinia ancestor appeared 42 to 187
million years ago and that Yersinia enterocolitica and Yersinia pseudotuberculosis
diverged from their common ancestor 0.4 to 1.9 million years ago. Most importantly,
this study showed that Yersinia pestis is a very recent clone, which emerged from Yersinia
pseudotuberculosis within the last 1500 to 20,000 years.
Plague: Diagnosis
Bacteriologicalidentificationof Yersinia pestis iscarried outonbiologicalsamplessuch
as bubo aspirates, blood, sputum, cerebrospinal fluids or organs (liver, spleen, lungs)
following post-mortem examination. Rapid presumption of plague infection can be
obtained by Wayson staining or by a fluorescent antibody test, but confirmation of the
diagnosis requires the isolation of the organism. This bacteriological identification may
take up to one week and cannot be performed by health agents in the field.
Other techniques have been developed over the last few years to improve the rapidity of
plague diagnosis. One of the most commonly available techniques is based on DNA
detection by polymerase chain reactions (PCR). However, the sensitivity of this technique
directly applied on biological samples is not always satisfactory and PCR is not applicable
in most field laboratories. A rapid diagnostic test (15minutes) has recently been developed
and validated in the field. This dipstick does not require any sophisticated equipment and
is now used routinely by public health agents in Madagascar.
14
Serological techniques may be useful for retrospective diagnosis when a treatment has
been administered to the patient without biological specimens being taken or when no
plague bacilli have been isolated from these specimens. Today, the most widely used
serodiagnostic test is based on enzyme-linked immunosorbent assay (ELISA).
Plague: Treatment and Prevention
Vaccines
The first mass vaccination campaigns against plague were carried out simultaneously in
1934 by Georges Girard and Jean-Marie Robic (strain EV) in Madagascar and by L Otten
(strainTjiwidej)inJavawithliveattenuatedplaguebacilli.
15Thesecampaignsresultedina
significant decrease in human morbidity and mortality, but the adverse reactions and the
short-termprotectionconferredbythesevaccinesledtoagradualdeclineintheirutilization.
Formalin-killed plague organisms have also been used to induce immunity in humans,
but the relatively low degree and short duration of protection, along with the adverse
effects conferredbythesevaccines,considerablylimitedtheir use.Today,severalacellular
or cellular recombinant vaccines are under study but they have not yet been tested in the
natural conditions of endemic and epidemic plague foci.
14SChanteau,LRahalison,LRalafiarisoa,JFoulon,MRatsitorahina,LRatsifasoamanana,ECarniel,FNato,
‘Developmentandtestingofarapiddiagnostictestforbubonicandpneumonicplague’,Lancet,2003,361:211–16.
15G Girard and J-M Robic, ‘La vaccination de l’homme contre la peste au moyen de bacilles vivants (virus
vaccin EV) son application a ` Madagascar’, Bull. Off. Int. Hyg. Publ. 1936: 28, 1078–87; L Otten, ‘Immunization
against plague with live vaccine’, Indian J. Med. Res., 1936, 24: 73–101.
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Prophylactic treatments are administered to close contacts of pneumonic plague
patients or to relatives of bubonic plague patients living in the same house. The treatment
consists most often in the administration of sulphonamides (single or repeated doses) or
tetracycline.
Antibiotic Therapy
The chances of patients’ survival are directly linked to the speed with which antibiotic
therapy is given, especially in the more severe pneumonic and septicaemic forms of the
disease.Theuseofantibioticstotreatplague,whichstartedin1938withsulphonamideand
in 1946 with streptomycin, led to a dramatic drop in human mortality. With the current
utilization of effective antibiotic therapy, the worldwide fatality rate attributable to plague
has fallen down to approximately 10 per cent. The three main antibiotics used to treat this
disease are streptomycin, tetracycline and chloramphenicol. The first is still the drug of
choice in several endemic countries, while the third is often restricted to meningeal forms.
Administration ofmono-,bi-, ortri-therapiesdepends ontheclinicalform ofplagueandon
the severity ofthesymptoms.Today,thesethreeantibiotics arenolongeravailable insome
countries and therefore two other molecules, gentamicin and fluoroquinolones, are used as
alternatives to the former treatments. However, it should be kept in mind that these
molecules have not yet been used to treat patients on a large scale.
Until recently, the plague bacillus was considered as universally susceptible to all
antibiotics used to treat Gram-negative infections. In 1995, the first multi-resistant strain
of Yersinia pestis was isolated in Madagascar from a patient with symptoms of bubonic
plague.This resistanceinvolved all the antibiotics recommended forplaguetherapy (strep-
tomycin, tetracycline and chloramphenicol) and prophylaxis (sulphonamides and tetracy-
cline),andalsoincludedantibioticsthatmayhaverepresentedtherapeuticalternativessuch
as ampicillin, kanamycin, spectinomycin, and minocycline. The resistance determinants
were carried by a conjugative plasmid which could be transferred to new Yersinia pestis
strains at high frequencies.
16 The acquisition of antibiotic resistance plasmids by Yersinia
pestis was subsequently shown to occur in the flea intestine.
17 Another point of significant
public health concern was the recent discovery that the multi drug resistance plasmid is
broadly disseminated among enterobacteria commonly isolated from food samples.
18
Conclusion
The study of modern plague teaches us that, although this disease may take on numerous
clinical forms, its diagnosis is still relatively easily made by local people in endemic areas
16MGalimand,AGuiyoule,GGerbaud,BRasoamanana,SChanteau,ECarniel,andPCourvalin,‘Multidrug
resistance in Yersinia pestis mediated by a transferable plasmid’, N. Engl. J. Med., 1997, 337 (10): 677–80.
17B JHinnebusch, M-L Rosso,T GSchwan,andE Carniel,‘High-frequency conjugative transferofantibiotic
resistance genes to Yersinia pestis in the flea midgut’, Molecular Microbiology, 2002, 46 (2): 349–54.
18T Welch, W F Fricke, P F McDermott, D G White, M-L Rosso, et al., ‘Multiple antimicrobial resistance in
plague: an emerging public health risk’, PLoS One, 2007, 2 (3): e309.
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Plague Todaybecause the overall clinical presentation is recognizable and different from any other
infection.
The comparison of the current plague foci in the world indicates that the type of flea
vectors, rodent reservoirs, climates, ecological landscapes and seasonality varies consid-
erably from one place to another. Since the characteristics of modern plague foci are so
different,it ishardly possible tocompare them with thoseof medievalplague.Theclimate,
fleas and rodents in Europe during the Middle Ages were obviously different from those
found in plague foci in Africa, Asia or America today. The ethnic group might also
influence the susceptibility to plague, as observed for several other diseases, including
AIDS. The human mode of living (chronic and abundant carriage of fleas, people living in
closecontact,oftenincities,etc.)isalsoquitedifferentfromthesituationmetinthecurrent
endemicfoci. Finally, the discoveryofthe aetiological agent, mode of transmission, rodent
reservoir, and the advent of antibiotics during the twentieth century have considerably
changedboth the mode of human infection andthe clinical presentations. Knowing that the
plague is a flea-borne infection has allowed us to implement simple measures, such as
disinsectization, thereby better controlling the spread of the disease at a local level. The
availabilityofeffective treatmentshas drastically reducedthe frequencyofthe mostsevere
forms of infections, thus changing the general clinical presentation.
Whether the devastating disease that killed a large portion of the human population
during the Middle Ages was plague (i.e. a Yersinia pestis infection) is currently a matter of
debate. Although we cannot prove anything one way or the other, it should be emphasized
that it is not possible to reject the plague aetiology of the Black Death simply because
certain symptoms and epidemiological features do not match those found today.
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